PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) Trial: Rationale and Design
Circulation. Heart failure - United States
doi 10.1161/circheartfailure.112.969071
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)